Importancia pronóstica de las distancias normalizadas entre el punto de captación máxima estandarizado del radiotrazador y el centro tumoral en la PET/TC con 18F-FDG en el carcinoma de células escamosas de cabeza y cuello

IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
S.-P. Hong , S.M. Lee , I.D. Yoo , I.Y. Jo , Y.K. Won , M.-S. Kim , H.J. Choi , J. Won Lee , S.J. Jang
{"title":"Importancia pronóstica de las distancias normalizadas entre el punto de captación máxima estandarizado del radiotrazador y el centro tumoral en la PET/TC con 18F-FDG en el carcinoma de células escamosas de cabeza y cuello","authors":"S.-P. Hong ,&nbsp;S.M. Lee ,&nbsp;I.D. Yoo ,&nbsp;I.Y. Jo ,&nbsp;Y.K. Won ,&nbsp;M.-S. Kim ,&nbsp;H.J. Choi ,&nbsp;J. Won Lee ,&nbsp;S.J. Jang","doi":"10.1016/j.remn.2025.500103","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>The maximum <sup>18</sup>F-FDG uptake of a cancer lesion has been found to relocate from the center to the periphery during progression. This behavior proposes that the normalized distances from the hotspot of radiotracer uptake to the tumor centroid (NHOC) and to the tumor perimeter (NHOP) could serve as novel geometric PET parameters indicative of tumor aggressiveness. This study aimed to explore the prognostic relevance of NHOC and NHOP in <sup>18</sup>F-FDG PET/CT for predicting the response to concurrent chemoradiotherapy (CCRT) and progression-free survival (PFS) in patients with head and neck squamous cell carcinoma.</div></div><div><h3>Materials and methods</h3><div>We retrospectively reviewed 116 head and neck squamous cell carcinoma patients who received CCRT and were assessed with pre-treatment (PET1) and 3 months post-treatment PET/CT (PET2). Along with conventional PET parameters, NHOC and NHOP for primary tumors on PET1 and the percent changes in NHOC and NHOP between PET1 and PET2 were measured.</div></div><div><h3>Results</h3><div>Of all the PET1 parameters assessed, NHOC was the most effective in predicting the CCRT response, achieving an area under the receiver operating characteristic curve of 0.645. In multivariate logistic regression and survival analysis, NHOC identified as an independent predictor for both complete metabolic response (p<!--> <!-->=<!--> <!-->0.028) and PFS (p<!--> <!-->=<!--> <!-->0.006). In a subgroup of 46 patients exhibiting residual primary tumors on PET2, both the percent changes in NHOC (p<!--> <!-->=<!--> <!-->0.048) and NHOP (p<!--> <!-->=<!--> <!-->0.041) were significantly associated with PFS.</div></div><div><h3>Conclusions</h3><div>NHOC and the percent changes in NHOC and NHOP following CCRT may serve as effective <sup>18</sup>F-FDG PET/CT parameters for predicting clinical outcomes in head and neck squamous cell carcinoma patients.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500103"},"PeriodicalIF":1.6000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola De Medicina Nuclear E Imagen Molecular","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2253654X25000010","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

The maximum 18F-FDG uptake of a cancer lesion has been found to relocate from the center to the periphery during progression. This behavior proposes that the normalized distances from the hotspot of radiotracer uptake to the tumor centroid (NHOC) and to the tumor perimeter (NHOP) could serve as novel geometric PET parameters indicative of tumor aggressiveness. This study aimed to explore the prognostic relevance of NHOC and NHOP in 18F-FDG PET/CT for predicting the response to concurrent chemoradiotherapy (CCRT) and progression-free survival (PFS) in patients with head and neck squamous cell carcinoma.

Materials and methods

We retrospectively reviewed 116 head and neck squamous cell carcinoma patients who received CCRT and were assessed with pre-treatment (PET1) and 3 months post-treatment PET/CT (PET2). Along with conventional PET parameters, NHOC and NHOP for primary tumors on PET1 and the percent changes in NHOC and NHOP between PET1 and PET2 were measured.

Results

Of all the PET1 parameters assessed, NHOC was the most effective in predicting the CCRT response, achieving an area under the receiver operating characteristic curve of 0.645. In multivariate logistic regression and survival analysis, NHOC identified as an independent predictor for both complete metabolic response (p = 0.028) and PFS (p = 0.006). In a subgroup of 46 patients exhibiting residual primary tumors on PET2, both the percent changes in NHOC (p = 0.048) and NHOP (p = 0.041) were significantly associated with PFS.

Conclusions

NHOC and the percent changes in NHOC and NHOP following CCRT may serve as effective 18F-FDG PET/CT parameters for predicting clinical outcomes in head and neck squamous cell carcinoma patients.
在头颈部鳞状细胞癌中,使用18F-FDG的PET/ CT中,标准放射示踪剂的最大采集点与肿瘤中心之间标准化距离的预测重要性
目的发现在肿瘤进展过程中,18F-FDG的最大摄取从中心向外周转移。这种行为表明,从放射性示踪剂摄取热点到肿瘤质心(NHOC)和肿瘤周长(NHOP)的归一化距离可以作为指示肿瘤侵袭性的新型几何PET参数。本研究旨在探讨NHOC和NHOP在18F-FDG PET/CT中预测头颈部鳞状细胞癌患者同步放化疗(CCRT)反应和无进展生存期(PFS)的预后相关性。材料与方法我们回顾性分析116例接受CCRT治疗的头颈部鳞状细胞癌患者,并对治疗前(PET1)和治疗后3个月的PET/CT (PET2)进行评估。在常规PET参数的基础上,测定PET1上原发肿瘤的NHOC和NHOP,以及PET1和PET2之间NHOC和NHOP的变化百分比。结果在所有评估的PET1参数中,NHOC预测CCRT反应最有效,其在受试者工作特征曲线下的面积为0.645。在多变量logistic回归和生存分析中,NHOC被确定为完全代谢反应(p = 0.028)和PFS (p = 0.006)的独立预测因子。在一个由46名在PET2上显示残留原发肿瘤的患者组成的亚组中,NHOC (p = 0.048)和NHOP (p = 0.041)的百分比变化与PFS显著相关。结论CCRT后snhoc及NHOC和NHOP百分比变化可作为预测头颈部鳞状细胞癌患者临床预后的有效18F-FDG PET/CT参数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Revista Espanola De Medicina Nuclear E Imagen Molecular
Revista Espanola De Medicina Nuclear E Imagen Molecular RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
CiteScore
1.10
自引率
16.70%
发文量
85
审稿时长
24 days
期刊介绍: The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging, which has more than 700 members. The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信